Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients

BACKGROUND: This study was initiated to investigate the difference in HER2 status between tumor tissue and circulating tumor cells (CTCs), as well as the predictive value of CTC HER2 status for predicting the outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer (MBC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Zhang, Shaohua, Li, Lei, Wang, Tao, Bian, Li, Hu, Haixu, Xu, Chunhong, Liu, Bing, Liu, Yi, Cristofanilli, Massimo, Jiang, Zefei
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4960713/
https://ncbi.nlm.nih.gov/pubmed/27456503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2578-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados